Figure 2
Figure 2. Myeloproliferative disease returns when AC220 treatment is discontinued. WBC counts are from 4 C57BL/6.CD45.1 mice repopulated with BM cells from a c-CblA/− mouse (A) and three 8- to 9-month-old naturally bred c-CblA/− mice (B). The mice were bled for 5 days before treatment commenced, after 6 weeks of daily dosing with vehicle or AC220, and 4 weeks after AC220 treatment was discontinued. (C) Blood films from a c-CblA/− mouse (M1173) before treatment, after 6 weeks of dosing with AC220, and 4 weeks after AC220 dosing was discontinued. The images were acquired at room temperature using an Olympus BX51 microscope with a 60×/0.09 objective and photographed with an SIS 3VCU Olympus digital camera. The WBC counts are shown and the scale bar indicates 50 μm.

Myeloproliferative disease returns when AC220 treatment is discontinued. WBC counts are from 4 C57BL/6.CD45.1 mice repopulated with BM cells from a c-CblA/− mouse (A) and three 8- to 9-month-old naturally bred c-CblA/− mice (B). The mice were bled for 5 days before treatment commenced, after 6 weeks of daily dosing with vehicle or AC220, and 4 weeks after AC220 treatment was discontinued. (C) Blood films from a c-CblA/− mouse (M1173) before treatment, after 6 weeks of dosing with AC220, and 4 weeks after AC220 dosing was discontinued. The images were acquired at room temperature using an Olympus BX51 microscope with a 60×/0.09 objective and photographed with an SIS 3VCU Olympus digital camera. The WBC counts are shown and the scale bar indicates 50 μm.

Close Modal

or Create an Account

Close Modal
Close Modal